Sell sideOpening bell: Myesha Lacy of Arcellx on the biotech’s IPO Jun 15, 2022Tim Human‘Why are you going public now?’ asked investors during biotech Arcellx’s IPO in early February this year. It was not a surprising...Read more
Small capMany US biotechs lack ESG disclosure, finds study Feb 16, 2022Tim HumanMany US biotechs have ‘limited or no explicit ESG disclosure’ despite recognizing the growing importance of sustainability to...Read more
CareersPyxis Oncology names new IR chief Nov 17, 2021Garnet RoachCourtney Dugan has been named vice president of investor relations, public relations and corporate communications at Cambridge,...Read more
Case studiesAdvisory Intelligence: ‘Deals and data’ are heartbeat of biotech Jun 08, 2021NASDAQSponsored content For companies in the biotech sector, 2021 is off to a fast start as capital-raising among new issuers...Read more
Buy sideUK biotech sector sees massive boost in 2018 Jan 25, 2019Andrew HoltThe UK biotech sector was given a massive boost last year when it raised a record £2.2 bn ($2.9 bn) from investors. New figures in a...Read more